| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Candidates Quality Significance (-10lgP) m/z RT range z Avg. Area Sample Profile Group Profile RT mean Start End Used PTM
K.VASGLGQEAAPLVDK.A Y 5.16 3.85 727.8968 68.59 - 74.64 2 3.1E6 70.96 84 98 Y
R.LLTAFNK.L Y 4.66 11.25 403.7418 59.00 - 66.94 2 2.5E6 62.33 44 50 Y
R.DFVEELR.A Y 5.16 4.79 454.2300 76.46 - 82.29 2 2.2E6 78.60 67 73 Y
R.AKPEFQALVK.V Y 3.57 6.48 377.5571 59.31 - 66.97 3 1.4E6 62.71 74 83 N
R.TAALGTYEHY.V Y 4.66 1.51 563.2651 57.33 - 65.25 2 1.3E6 60.36 101 110 N
R.AKPEFQALVK.V Y 4.56 12.25 565.8324 59.34 - 67.00 2 1.1E6 62.71 74 83 N
Y.VRPHVGQQLSDSIDR.I Y 4.61 0.70 569.6363 45.85 - 56.63 3 1.1E6 49.40 111 125 N
K.LHASAVASADSGPNAR.D Y 1.22 0.76 508.5917 31.97 - 47.64 3 1E6 35.82 51 66 N
K.SVFYQR.L Y 4.77 12.41 400.2091 43.56 - 54.33 2 8.8E5 47.01 38 43 N
R.TAALGTYEHYVRPHVGQQLSDSIDR.I Y 2.27 8.07 704.1045 79.54 - 84.81 4 5.1E5 81.87 101 125 N
K.LHASAVASADSGPNAR.D Y 2.01 3.93 762.3808 32.05 - 45.67 2 3.8E5 35.81 51 66 N
R.DFVEELR.A Y 3.33 4.65 907.4532 76.46 - 81.96 1 3.1E5 78.61 67 73 N
K.SVFYQR.L Y 3.43 22.90 799.4101 43.60 - 53.37 1 2.5E5 47.00 38 43 N
R.LLTAFNK.L Y 3.19 10.80 806.4768 58.96 - 66.91 1 2.2E5 62.30 44 50 N
Y.VRPHVGQQLSDSIDR.I Y 1.93 1.28 427.4787 45.85 - 56.66 4 1.9E5 49.55 111 125 N
Y.VRPHVGQQLSDSIDR.I Y 2.01 3.88 853.9508 45.85 - 57.06 2 1.4E5 49.57 111 125 N
K.LHASAVASADSGPN(+.98)AR.D Y 0.44 0.42 508.9273 32.57 - 36.68 3 1.4E5 34.73 51 66 N Deamidation (NQ)
R.TAALGTYEHYVRPHVGQQLSDSIDR.I Y 1.82 12.87 563.4848 79.51 - 84.68 5 1.3E5 81.87 101 125 N
R.TAALGTYEHYVRPHVGQQLSDSIDR.I Y 2.00 11.23 938.4685 79.51 - 84.48 3 1E5 81.86 101 125 N
R.A(+43.01)KPEFQALVK.V Y 1.50 5.04 587.3356 79.40 - 84.24 2 1E5 81.48 74 83 N Carbamylation
K.VYLDMFLPTQ Y 2.66 60.00 613.8113 132.92 - 135.37 2 9.9E4 133.50 128 137 N
K.V(+43.01)ASGLGQEAAPLVDK.A Y 2.15 2.23 749.3960 100.34 - 103.81 2 9.2E4 101.59 84 98 N Carbamylation
Y.V(+43.01)RPHVGQQLSDSIDR.I Y 2.40 0.12 583.9713 61.78 - 68.30 3 9.1E4 64.47 111 125 N Carbamylation
R.TAALGTYEHY.V Y 3.01 2.05 1125.5205 57.37 - 65.52 1 7.5E4 60.41 101 110 N
K.L(+43.01)HASAVASADSGPNAR.D Y 1.29 2.27 783.8847 47.96 - 58.03 2 5.9E4 51.64 51 66 N Carbamylation
R.L(+43.01)LTAFNK.L Y 2.81 8.89 425.2449 126.45 - 128.87 2 5.3E4 127.56 44 50 N Carbamylation
R.IKVYLDMFLPTQ Y 1.52 32.33 734.3978 132.33 - 134.56 2 5E4 133.08 126 137 N
K.VASGLGQE(+21.98)AAPLVDK.A Y 1.95 1.60 738.8866 68.49 - 74.53 2 4.9E4 70.97 84 98 N Sodium adduct
K.VASGLGQEAAPLVDK.A Y 1.62 4.19 485.6019 68.42 - 74.51 3 4.8E4 70.98 84 98 N
R.T(+43.01)AALGTYEHY.V Y 1.68 0.26 584.7671 81.80 - 85.46 2 4.5E4 83.22 101 110 N Carbamylation
K.VYLDMFLPTQ Y 2.72 60.00 1226.6146 132.96 - 133.88 1 3.7E4 133.21 128 137 N
R.D(+43.01)FVEELR.A Y 1.89 4.90 475.7324 101.64 - 105.23 2 3.6E4 103.08 67 73 N Carbamylation
R.L(+43.01)LTAFNK.L Y 2.21 3.81 849.4821 126.50 - 128.84 1 3.4E4 127.59 44 50 N Carbamylation
R.AKPEFQALVK.V Y 1.17 1.35 377.5579 60.86 - 68.76 3 2.8E4 64.19 74 83 N
R.AKPEFQALVK.V Y 2.55 4.38 1130.6543 59.37 - 66.97 1 2.7E4 62.70 74 83 N
K.Y(+43.01)DSMK.S Y 1.93 3.58 686.2824 40.47 - 50.15 1 2.6E4 43.82 33 37 N Carbamylation
R.D(+43.01)FVEELR.A Y 1.21 4.61 950.4551 101.49 - 106.18 1 2.1E4 103.11 67 73 N Carbamylation
R.LLTAFNK.L Y 0.23 3.82 403.7424 60.72 - 68.36 2 2.1E4 63.49 44 50 N
Y.EHYVRPHVGQQLSDSIDR.I Y 0.47 2.12 534.7722 50.25 - 55.38 4 2.1E4 53.65 108 125 N
R.TAALGTYEHYVR.P Y 0.72 2.17 460.9036 61.99 - 68.39 3 1.9E4 64.76 101 112 N
K.VASGLGQEAAPLVDK.A Y 1.99 5.63 1454.7829 68.59 - 74.45 1 1.8E4 71.03 84 98 N
K.S(+43.01)VFYQR.L Y 0.68 1.57 421.7116 65.40 - 69.40 2 1.6E4 67.85 38 43 N Carbamylation
K.YDSMK.S Y 1.67 4.77 322.1430 27.49 - 30.06 2 1.5E4 28.86 33 37 N
K.L(+43.01)HASAVASADSGPNAR.D Y 0.28 0.17 522.9341 48.03 - 58.06 3 1.4E4 51.76 51 66 N Carbamylation
R.PHVGQQLSDSIDR.I Y 0.76 1.21 726.3640 48.10 - 56.99 2 1.3E4 51.55 113 125 N
K.LHASAVASADSGPNAR.D Y 0.08 2.76 762.3862 34.62 - 43.92 2 1.2E4 40.59 51 66 N
R.DFVEELR.A Y 0.15 1.77 454.2337 79.47 - 84.31 2 1.2E4 82.28 67 73 N
R.TAALGTYEHYVR.P Y 0.52 1.71 690.8531 61.71 - 66.18 2 9.8E3 64.10 101 112 N
R.AKPEFQALVK.V Y 0.19 2.12 565.8372 61.00 - 65.15 2 9.5E3 63.64 74 83 N
K.VASGLGQ(+.98)EAAPLVDK.A Y 0.41 1.94 728.3805 72.12 - 76.78 2 8.5E3 74.06 84 98 N Deamidation (NQ)
K.LHASAVASADSGPNAR.D Y 0.27 0.78 762.3813 42.07 - 52.21 2 8E3 46.38 51 66 N
R.DFVEELR.A Y 0.20 2.32 454.2359 87.91 - 93.84 2 6.5E3 90.15 67 73 N
K.VASGLGQEAAPLVDK.A Y 0.20 1.31 727.8959 70.55 - 76.52 2 6.4E3 74.23 84 98 N
C.QLPEPSPELVQK.Y Y 0.55 0.99 682.8751 90.80 - 94.50 2 6.4E3 92.38 21 32 N
R.DFVEELR.A Y 0.23 1.58 454.2310 75.16 - 77.26 2 5.7E3 76.18 67 73 N
H.ASAVASADSGPNAR.D Y 0.56 1.00 637.3222 27.54 - 31.43 2 5.5E3 28.75 53 66 N
K.LHASAVASADSGPNAR.D Y 0.37 8.29 508.5944 126.95 - 133.78 3 4.8E3 128.52 51 66 N
K.LHASAVASAD(+21.98)SGPNAR.D Y 0.05 0.11 515.9185 34.44 - 42.81 3 4.3E3 37.72 51 66 N Sodium adduct
R.TAALGTYEHYVRPHVGQQLS(-18.01)DSIDR.I Y 0.40 7.67 699.6111 79.04 - 82.37 4 4E3 80.42 101 125 N Phospho neutral loss (ST)
K.VYLDM(+15.99)FLPTQ Y 0.27 7.02 621.8127 123.55 - 125.67 2 3.6E3 124.90 128 137 N Oxidation (M)
K.LHASAVASADSGPNAR.D Y 0.53 7.40 508.5941 129.84 - 134.71 3 2.9E3 130.81 51 66 N
K.VYLDMFLPTQ(+21.98) Y 0.28 4.63 624.8045 130.39 - 133.60 2 2.7E3 132.80 128 137 N Sodium adduct
K.LHASAVASADS(-18.01)GPNAR.D Y 0.15 6.29 753.3842 34.95 - 39.44 2 1.8E3 37.24 51 66 N Phospho neutral loss (ST)
R.A(+43.01)KPEFQALVK.V Y 0.52 7.53 391.8959 79.47 - 81.53 3 1.3E3 80.63 74 83 N Carbamylation
K.LHASAVASADSGPNAR.D Y 0.23 6.37 508.5979 126.05 - 131.22 3 671.7 127.20 51 66 N
K.LHASAVASADSGPNAR.D Y 0.06 5.61 508.5956 124.35 - 129.71 3 435.7 125.21 51 66 N
total 66 peptides